Akebia Therapeutics Stock (NASDAQ: AKBA) stock price, news, charts, stock research, profile.
You can purchase shares of Akebia Therapeutics (NASDAQ:AKBA) through any online brokerage.
Other companies in Akebia Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Akebia Therapeutics has a consensus price target of $3.90.
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $1.344 last updated September 25, 2024 at 11:54 AM EDT.
There are no upcoming dividends for Akebia Therapeutics.
Akebia Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Akebia Therapeutics.
Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.